Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 10;27(6):859-862.
doi: 10.1016/j.chom.2020.04.011.

Call to Action: How to Tackle Emerging Nosocomial Fungal Infections

Michail S Lionakis  1 , Tobias M Hohl  2
Affiliations

Call to Action: How to Tackle Emerging Nosocomial Fungal Infections

Michail S Lionakis et al. Cell Host Microbe. .

Abstract

Nosocomial fungal infections require a robust scientific response to complement antifungal development and the implementation of infection control measures. This Commentary discusses how a parallel effort to address fungal pathogenesis and antifungal immunity, the mycobiota and colonization resistance, and risk factors is essential to reduce the toll of these infections.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests The authors declare no competing interests.

References

    1. Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019. Atlanta: CDC; https://www.cdc.gov/drugresistance/pdf/threats-report/2019-arthreats-rep....
    1. Chamilos G, Lionakis MS, and Kontoyiannis DP (2018). Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways. Clin. Infect. Dis 66, 140–148. - PMC - PubMed
    1. Drummond RA, Swamydas M, Oikonomou V, Zhai B, Dambuza IM, Schaefer BC, Bohrer AC, Mayer-Barber KD, Lira SA, Iwakura Y, et al. (2019). CARD9+ microglia promote antifungal immunity via IL-1b- and CXCL1-mediated neutrophil recruitment. Nat. Immunol 20, 559–570. - PMC - PubMed
    1. Edwards JE Jr., Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, et al. (2018). A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Clin. Infect. Dis 66, 1928–1936. - PMC - PubMed
    1. Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, and Koh AY (2015). Activation of HIF-1a and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med 21, 808–814. - PMC - PubMed

Publication types

Substances